PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-46.12%
Both yoy net incomes decline, with MRVL at -2786.45%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
8.09%
Some D&A expansion while MRVL is negative at -6.16%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-140.89%
Negative yoy deferred tax while MRVL stands at 726.80%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
4.90%
SBC growth while MRVL is negative at -2.71%. John Neff would see competitor possibly controlling share issuance more tightly.
-143.00%
Both reduce yoy usage, with MRVL at -93.18%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-13.87%
Both yoy AR lines negative, with MRVL at -106.25%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-49.73%
Both reduce yoy inventory, with MRVL at -37.92%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
39.34%
Lower AP growth vs. MRVL's 9830.59%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-373.04%
Both reduce yoy usage, with MRVL at -2338.56%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
1782.43%
Well above MRVL's 0.79%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-42.93%
Both yoy CFO lines are negative, with MRVL at -43.75%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-32.23%
Negative yoy CapEx while MRVL is 18.55%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
40.00%
Some acquisitions while MRVL is negative at -189.34%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
54.81%
Purchases growth of 54.81% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-7.28%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-250.00%
We reduce yoy other investing while MRVL is 116.23%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
264.59%
We have mild expansions while MRVL is negative at -30.61%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
97.82%
Debt repayment similar to MRVL's 89.20%. Walter Schloss sees parallel liability management or similar free cash flow availability.
-100.00%
Both yoy lines negative, with MRVL at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-220.90%
We cut yoy buybacks while MRVL is 89.03%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.